| scholarly article | Q13442814 |
| P50 | author | Rolf Lood | Q87922609 |
| P2093 | author name string | Vincent A Fischetti | |
| Henrik Molina | |||
| P2860 | cites work | Highly adaptable and sensitive protease assay based on fluorescence resonance energy transfer. | Q53221563 |
| Internally quenched peptides for the study of lysostaphin: An antimicrobial protease that kills Staphylococcus aureus. | Q53588360 | ||
| A new lysozyme assay based on fluorescence polarization or fluorescence intensity utilizing a fluorescent peptidoglycan substrate | Q71440038 | ||
| Bacteriophage lysins as effective antibacterials | Q24648457 | ||
| Multiple enzymatic activities of the murein hydrolase from staphylococcal phage phi11. Identification of a D-alanyl-glycine endopeptidase activity | Q28144392 | ||
| Biochemical and biophysical characterization of PlyGRCS, a bacteriophage endolysin active against methicillin-resistant Staphylococcus aureus | Q30009348 | ||
| Skyline: an open source document editor for creating and analyzing targeted proteomics experiments | Q30080030 | ||
| Cell wall-targeting domain of glycylglycine endopeptidase distinguishes among peptidoglycan cross-bridges | Q30160087 | ||
| Synergism between a novel chimeric lysin and oxacillin protects against infection by methicillin-resistant Staphylococcus aureus | Q33525230 | ||
| Surface proteins of gram-positive bacteria and mechanisms of their targeting to the cell wall envelope | Q33538951 | ||
| A highly active and negatively charged Streptococcus pyogenes lysin with a rare D-alanyl-L-alanine endopeptidase activity protects mice against streptococcal bacteremia | Q33797903 | ||
| A peptide-based fluorescence resonance energy transfer assay for Bacillus anthracis lethal factor protease | Q34067110 | ||
| The antimicrobial resistance crisis: causes, consequences, and management | Q34192579 | ||
| FRET-based and other fluorescent proteinase probes. | Q35086168 | ||
| Novel phage lysin capable of killing the multidrug-resistant gram-negative bacterium Acinetobacter baumannii in a mouse bacteremia model | Q35168859 | ||
| Bacteriophage lytic enzymes: novel anti-infectives | Q36242302 | ||
| Structural characterization of peptidoglycan muropeptides by matrix-assisted laser desorption ionization mass spectrometry and postsource decay analysis | Q36864633 | ||
| Novel bacteriophage lysin with broad lytic activity protects against mixed infection by Streptococcus pyogenes and methicillin-resistant Staphylococcus aureus | Q37026612 | ||
| Use of 4-sulfophenyl isothiocyanate labeling and mass spectrometry to determine the site of action of the streptococcolytic peptidoglycan hydrolase zoocin A | Q37032910 | ||
| Lysostaphin: an antistaphylococcal agent | Q37209589 | ||
| Visualization of human immunodeficiency virus protease inhibition using a novel Förster resonance energy transfer molecular probe | Q38267082 | ||
| Analysis of peptidoglycan structure from vegetative cells of Bacillus subtilis 168 and role of PBP 5 in peptidoglycan maturation. | Q39496321 | ||
| Rapid killing of Streptococcus pneumoniae with a bacteriophage cell wall hydrolase | Q43820230 | ||
| Development of a novel fluorescent substrate for Autolysin E, a bacterial type II amidase. | Q46089091 | ||
| Lack of development of new antimicrobial drugs: a potential serious threat to public health | Q48002635 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P4510 | describes a project that uses | liquid chromatography–mass spectrometry | Q873864 |
| P433 | issue | 3 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bacteriophage | Q165028 |
| P304 | page(s) | e0173919 | |
| P577 | publication date | 2017-03-15 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Determining bacteriophage endopeptidase activity using either fluorophore-quencher labeled peptides combined with liquid chromatography-mass spectrometry (LC-MS) or Förster resonance energy transfer (FRET) assays | |
| P478 | volume | 12 |
| Q92264517 | Exebacase in Addition to Daptomycin Is More Active than Daptomycin or Exebacase Alone in Methicillin-Resistant Staphylococcus aureus Osteomyelitis in Rats |
| Q92050162 | Implications of Bacteriophage- and Bacteriophage Component-Based Therapies for the Clinical Microbiology Laboratory |
| Q92764958 | Postantibiotic and Sub-MIC Effects of Exebacase (Lysin CF-301) Enhance Antimicrobial Activity against Staphylococcus aureus |
Search more.